Human thyroid epithelial cells cultured in monolayers. II. Influence of serum on thyroglobulin and cAMP production

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

An in vitro system of secondary cultures of human thyroid follicular epithelial cells in monolayer is described. The 72-h influence of serum and six supplements (thyrotropin, insulin, somatostatin, transferrin, hydrocortisone, glycyl-histidyl-lysine acetate) on growth and function in presence of 3-isobutyl-L-methyl-xanthine (IBMX) was investigated. The function of the cells was evaluated by production of the second messenger adenylate cyclase (cAMP) and the end product thyroglobulin (Tg). Growth was measured as the 3H-thymidine uptake of the cells. Three days of TSH-depletion preceeded the experiments. In presence of IBMX TSH stimulated cAMP production, while stimulation of Tg was only present in some cultures. In absence of IBMX TSH always stimulated the Tg production. The stimulation was independent of the presence of the other five investigated nutritional factors in physiological concentrations. TSH in concentrations from 0.1-10 U/l stimulated the 72ih 3H-thymidine uptake of the cells. The TSH-stimulated production of Tg and cAMP decreased significantly with increasing concentrations of fetal calf serum (0-10%), (τ = 0.49, P < 0.001, n = 6-29 and τ = 0.75, P < 0.001, n = 6-29, respectively). Thus, serum as a complex, variable and not fully characterized mixture of hormones and growth factors was crucial to the attachment of the cells to the substrate, but inhibited differentiated functions of the human thyroid cells.

OriginalsprogEngelsk
TidsskriftMolecular and Cellular Endocrinology
Vol/bind116
Udgave nummer2
Sider (fra-til)173-179
Antal sider7
ISSN0303-7207
DOI
StatusUdgivet - 1996

Bibliografisk note

Funding Information:
ated in the surgical departments of Frederiksberg Hospital, Rigshospitalet and Herlev Hospital, University of Copenhagen, the chiefs of which are thanked for very valuable cooperation. The excellent technical assistance of Lisbeth Kirkegaard is gratefully acknowledged. A.K. Rasmussen is the recipient of a fellowship award from the Alfred Benzon Foundation, Copenhagen, Denmark. The study was supported by grants from the foundations of the Danish Cancer Society, Danish Hospital Foundation for Medical Research-Region of Copenhagen, the Faroe Islands and Greenland the Danish Medical Research Council, the Novo Nordisk Foundation, the ,Alfred Benzon Foundation and EEC-project no: SC1 -CT91 0707.

ID: 335354867